Therapeutic potential of stem cells in perinatal medicine

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 45, Issue 2, 2005, Pages 102-107

  Santner Nanan, Brigitte ^a   Peek, Michael J ^a   McCullagh, Peter ^a   Nanan, Ralph ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b NEPEAN HOSPITAL   (Australia)

Author keywords

Human umbilical cord blood; Neonate; Stem cells; Tissue damage

Indexed keywords

ADENOSINE DEAMINASE; BASIC FIBROBLAST GROWTH FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; DNA; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GROWTH HORMONE; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN RECEPTOR; NEUROTROPHIN; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

AUTOLOGOUS STEM CELL TRANSPLANTATION; BRAIN INJURY; BRAIN ISCHEMIA; CELL MIGRATION; CELL SECRETION; CHILD GROWTH; EMBRYO CELL; ENZYME DEFICIENCY; EVIDENCE BASED MEDICINE; FETUS BLOOD; GENE THERAPY; GENETIC DISORDER; GROWTH HORMONE RELEASE; HUMAN; LUNG INJURY; MEDICAL LITERATURE; MEDICAL RESEARCH; MODULATION; NEWBORN CARE; NEWBORN PERIOD; NONHUMAN; PATHOPHYSIOLOGY; PEER REVIEW; PERINATAL CARE; PERINATOLOGY; PLACENTA; PRIORITY JOURNAL; PROTECTION; PUBLICATION; REVIEW; SCORING SYSTEM; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; TISSUE INJURY; TISSUE REPAIR; UMBILICAL CORD BLOOD;

ANIMALS; BRAIN INJURIES; FEMALE; FETAL BLOOD; HUMANS; INFANT, NEWBORN; MODELS, ANIMAL; OBSTETRICS; PERINATOLOGY; PLACENTA; PREGNANCY; REGENERATION; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 17244378423     PISSN: 00048666     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2005.00362.x     Document Type: Review

References (66)

1. Wolpert L. Stem cells: A problem in asymmetry. J. Cell Sci Suppl. 1988; 10: 1-9.
2. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998; 282: 1827. Erratum in: Science 1998 Dec 4;282(5395):1827.
3. Bjorklund LM, Sanchez-Pernaute R, Chung S et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci USA. 2002; 99: 2344-2349.
4. Lo KC, Chuang WW, Lamb DJ. Stem cell research: the facts, the myths and the promises. J Urol. 2003; 170: 2453-2458.
5. Mancuso S. Stem cell research need not be carried out utilizing human embryos. Reprod Biomed Online. 2003; 6: 168-169.
6. Blau HM, Brazelton TR, Weimann JM. The evolving concept of a stem cell: entity or function? Cell. 2001; 105: 829-841.
7. Horwitz EM. Stem cell plasticity: the growing potential of cellular therapy. Arch Med Res. 2003; 34: 600-606.
8. Caplan AI, Bruder SP. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med. 2001; 7: 259-264.
9. Pereira RF, Halford KW, O'Hara MD et al. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci USA. 1995; 92: 4857-4861.
10. Kopen GC, Prockop DJ, Phinney DG. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci USA. 1999; 96: 10711-10716.
11. Liechty KW, MacKenzie TC, Shaaban AF et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med. 2000; 6: 1282-1286.
12. Theise ND, Nimmakayalu M, Gardner R et al. Liver from bone marrow in humans. Hepatology. 2000; 32: 11-16.
13. Kleeberger W, Rothamel T, Glockner S, Flemming P, Lehmann U, Kreipe H. High frequency of epithelial chimerism in liver transplants demonstrated by microdissection and STR-analysis. Hepatology. 2002; 35: 110-116.
14. Quaini F, Urbanek K, Beltrami AP et al. Chimerism of the transplanted heart. N Engl J Med. 2002; 346: 5-15.
15. Suratt BT, Cool CD, Serls AE et al. Human pulmonary chimerism after hematopoietic stem cell transplantation. Am J Respir Crit Care Med. 2003; 168: 318-322.
16. Weimann JM, Charlton CA, Brazelton TR, Hackman RC, Blau HM. Contribution of transplanted bone marrow cells to Purkinje neurons in human adult brains. Proc Natl Acad Sci USA. 2003; 100: 2088-2093.
17. Uchida N, Buck DW, He D et al. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci USA. 2000; 97: 14720-14725.
18. Palmer TD, Schwartz. PH, Taupin P, Kaspar B, Stein SA, Gage FH. Cell culture. Progenitor cells from human brain after death. Nature. 2001; 411: 42-3.
19. Roisen FJ, Klueber KM, Lu CL et al. Adult human olfactory stem cells. Brain Res. 2001; 890: 11-22.
20. Broxmeyer HE, Gluckman E, Auerbach A et al. Human umbilical cord blood: a clinically useful source of transplantable hematopoietic stem/progenitor cells. Int J Cell Cloning. 1990; 8 76-89.
21. Mayani H, Lansdorp PM. Biology of human umbilical cord blood-derived hematopoietic stem/progenitor cells. Stem Cells. 1998; 16: 153-165.
22. Eichler H, Schaible T, Richter E et al. Cord blood as a source of autologous RBCs for transfusion to preterm infants. Transfusion. 2000; 40: 1111-1117.
23. Brune T, Garritsen H, Witteler R et al. Autologous placental blood transfusion for the therapy of anaemic neonates. Biol Neonate. 2002; 81: 236-243.
24. Taguchi T, Suita S, Nakamura M et al. The efficacy of autologous cord-blood transfusions in neonatal surgical patients. J Pediatr Surg. 2003; 38: 604-607.
25. Lansdorp PM, Dragowska W, Mayani H. Ontogeny-related changes in proliferative potential of human hematopoietic cells. J Exp Med. 1993; 178: 787-791.
26. Voermans C, Gerritsen WR, von dem Borne AE, van der Schoot CE. Increased migration of cord blood-derived CD34+ cells, as compared to bone marrow and mobilized peripheral blood CD34+ cells across uncoated or fibronectin-coated filters. Exp Hematol. 1999; 27: 1806-1814.
27. Tanavde VM, Malehorn MT, Lumkul R et al. Human stem-progenitor cells from neonatal cord blood have greater hematopoietic expansion capacity than those from mobilized adult blood. Exp Hematol. 2002; 30: 816-823.
28. Apperley JF. Umbilical cord blood progenitor cell transplantation. The International Conference Workshop on Cord Blood Transplantation, Indianapolis, November 1993. Bone Marrow Transplant 1994; 14: 187-196.
29. Hao QL, Shah AJ, Thiemann FT, Smogorzewska EM, Crooks GM. A functional comparison of CD34 + CD38- cells in cord blood and bone marrow. Blood. 1995; 86: 3745-3753.
30. Flotte TR, Carter BJ. In vivo gene therapy with adeno-associated virus vectors for cystic fibrosis. Adv Pharmacol. 1997; 40: 85-101.
31. Wilson JM, Grossman M, Raper SE, Baker JR Jr, Newton RS, Thoene JG. Ex vivo gene therapy of familial hypercholesterolemia. Hum Gene Ther. 1992; 3: 179-222.
32. Liu JM, Young NS, Walsh CE et al. Retroviral mediated gene transfer of the Fanconi anemia complementation group C gene to hematopoietic progenitors of group C patients. Hum Gene Ther. 1997; 8: 1715-1730.
33. Parkman R, Weinberg K, Crooks G, Nolta J, Kapoor N, Kohn D. Gene therapy for adenosine deaminase deficiency. Annu Rev Med. 2000; 51: 33-47.
34. Myers LA, Patel DD, Puck JM, Buckley RH. Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival. Blood 2002; 99: 872-878.
35. Becker PS. Hematopoietic stem cell gene therapy for inherited bone marrow disorders: past accomplishments and continued challenges. J. Cell Biochem Suppl. 2002; 38: 55-64.
36. Yeung F, Chung LW. Molecular basis of co-targeting prostate tumor and stroma. J Cell Biochem Suppl. 2002; 38: 65-72.
37. Devine SM. Mesenchymal stem cells: will they have a role in the clinic? J Cell Biochem Suppl. 2002; 38: 73-79.
38. Schwarzenberger P, Kolls JK. Interleukin 17: an example for gene therapy as a tool to study cytokine mediated regulation of hematopoiesis. J Cell Biochem Suppl. 2002; 38: 88-95.
39. Tse WT, Egalka MC. Stem cell plasticity and blood and marrow transplantation: a clinical strategy. J Cell Biochem. Suppl 2002; 38: 96-103.
40. Kohn DB, Hershfield MS, Carbonaro D et al. T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates. Nat Med. 1998; 4: 775-780.
41. du Plessis AJ, Volpe JJ. Perinatal brain injury in the preterm and term newborn. Curr Opin Neurol. 2002; 15: 151-157.
42. Haworth SG, Hislop AA. Lung development-the effects of chronic hypoxia. Semin Neonatol. 2003; 8: 1-8.
43. Krause DS, Theise ND, Collector MI et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell. 2001; 105: 369-377.
44. Salsbury DC. Anemia of prematurity. Neonatal Netw. 2001; 20: 13-20.
45. Biorklund A, Lindvall O. Cell replacement therapies for central nervous system disorders. Nat Neurosci. 2000; 3: 537-544.
46. Taupin P, Gage FH. Adult neurogenesis and neural stem cells of the central nervous system in mammals. J. Neurosci Res. 2002; 69: 745-749.
47. Sanai N, Tramontin AD, Quinones-Hinojosa A et al. Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration. Nature. 2004; 427: 740-744.
48. Leviton A, Gilles F. Ventriculomegaly, delayed myelination, white matter hypoplasia, and 'periventricular' leukomalacia: how are they related? Pediatr Neurol. 1996; 15: 127-136.
49. Back SA, Han BH, Luo NL et al. Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J. Neurosci. 2002; 22: 455-463.
50. Eglitis MA, Mezey E. Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc Natl Acad Sci USA. 1997; 94: 4080-4085.
51. Asheuer M, Pflumio F, Benhamida S et al. Human CD34+ cells differentiate into microglia and express recombinant therapeutic protein. Proc Natl Acad Sci USA 2004; 101: 3557-3562.
52. Bonilla S, Alarcon P, Villaverde R, Aparicio P, Silva A, Martinez S. Haematopoietic progenitor cells from adult bone marrow differentiate into cells that express oligodendroglial antigens in the neonatal mouse brain. Eur J Neurosci. 2002; 15: 575-582.
53. Morshead CM, Benveniste P, Iscove NN, van der Kooy D. Hematopoietic competence is a rare property of neural stem cells that may depend on genetic and epigenetic alterations. Nat Med. 2002; 8 268-273.
54. Wagers AJ, Sherwood RI, Christensen JL, Weissman IL. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science. 2002; 297: 2256-2259.
55. Abe K. Therapeutic potential of neurotrophic factors and neural stem cells against ischemic brain injury. J Cereb Blood Flow Metab 2000; 20: 1393-1408.
56. Johansson CB. Mechanism of stem cells in the central nervous system. J Cell Physiol.. 2003; 196: 409-418.
57. Terada N, Hamazaki T, Oka M et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 2002; 416: 485-487.
58. Ying QL, Nichols J, Evans EP, Smith AG. Changing potency by spontaneous fusion. Nature. 2002; 416: 545-548.
59. Beltrami AP, Barlucchi L, Torella D et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003; 114: 763-776.
60. Hein WR, Griebel PJ. A road less travelled: large animal models in immunological research. Nat Rev Immunol. 2003; 3: 79-84.
61. Hagberg H, Peebles D, Mallard C. Models of white matter injury: comparison of infectious, hypoxic-ischemic, and excitotoxic insults. Ment Retard Dev Disabil Res Rev. 2002; 8: 30-38.
62. Airey JA, Almeida-Porada G, Colletti EJ et al. Human mesenchymal stem cells form Purkinje fibers in fetal sheep heart. Circulation. 2004; 109: 1401-1407.
63. Noia G, Pierelli L, Bonanno G et al. A novel route of transplantation of human cord blood stem cells in preimmune fetal sheep: the intracelomic cavity. Stem Cells. 2003; 21: 638-646.
64. Almeida-Porada G, El Shabrawy D, Porada C, Zanjani ED. Differentiative potential of human metanephric mesenchymal cells. Exp Hematol. 2002; 30: 1454-1462.
65. McNiece IK, Almeida-Porada G, Shpall Ej, Zanjani E. Ex vivo expanded cord blood cells provide rapid engraftment in fetal sheep but lack long-term engrafting potential. Exp Hematol. 2002; 30: 612-616.
66. Lewis ID, Almeida-Porada G, Du J et al. Umbilical cord blood cells capable of engrafting in primary, secondary, and tertiary xenogeneic hosts are preserved after ex vivo culture in a non-contact system. Blood. 2000; 97: 3441-3449.